DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Background. Dystroglycanopathies (DGPs) constitute a set of recessive, neuromuscular congenital dystrophies that result from impaired glycosylation of dystroglycan (DG).